Literature DB >> 15167871

Endoscopic retrograde cholangiopancreatography (ERCP) in pregnancy without the use of radiation.

D C Simmons1, P R Tarnasky, M E Rivera-Alsina, J F Lopez, C D Edman.   

Abstract

BACKGROUND: Biliary disease in pregnancy is a relatively uncommon condition; the diagnosis of this condition is not standardized. Furthermore, the use of radiographic imaging studies and therapeutic approaches in pregnancy is limited because of the possibility of fetal exposure. STUDY
DESIGN: During a 2-year interval of 2001 to 2002, we successfully performed endoscopic retrograde cholangiopancreatography (ERCP) studies in 6 pregnant women between 6 and 30 weeks of gestation with symptomatic acute cholangitis or pancreatitis without irradiation exposure or major maternal complications. Five of the women had classic symptoms of severe right upper quadrant abdominal pain, gallbladder stones, jaundice, and dilated bile ducts on ultrasonic evaluation. One woman had severe recurrent pancreatitis during early pregnancy 4 years after a cholecystectomy. The cases are compiled to provide a descriptive review of ERCP without the use of radiation imaging treatment for these conditions.
RESULTS: Maternal outcome: After ERCP, jaundice resolved in all cases. No further episodes of pancreatitis occurred during the 1 affected pregnancy. No post-ERCP complications occurred during this series. Two patients required cholecystectomy later, one in the postpartum period and the other 5 weeks post-ERCP. Fetal outcome: Two infants were born at term without complications. Two infants were born prematurely at 35 weeks, 1 with significant growth retardation and pulmonary complications and 1 without developmental problems or complications. Two mothers were lost to follow-up; the outcomes of their pregnancies are unknown.
CONCLUSION: The use of ERCP in pregnancy is limited because of the undesirable effects of radiation exposure to the fetus.

Entities:  

Mesh:

Year:  2004        PMID: 15167871     DOI: 10.1016/j.ajog.2004.02.030

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

Review 1.  Risks versus benefits of gastrointestinal endoscopy during pregnancy.

Authors:  Mitchell S Cappell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-04       Impact factor: 46.802

2.  Role of endoscopic ultrasound/SpyScope in diagnosis and treatment of choledocholithiasis in pregnancy.

Authors:  Mohit Girotra; Niraj Jani
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

3.  ERCP in pregnancy: is it safe?

Authors:  Adel Y Daas; Amir Agha; Haim Pinkas; Jay Mamel; Patrick G Brady
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-12

4.  [Perinatal risk in emergent surgery].

Authors:  J W Dudenhausen; W Henrich
Journal:  Chirurg       Date:  2005-08       Impact factor: 0.955

Review 5.  Acute pancreatitis during pregnancy: a review.

Authors:  G Ducarme; F Maire; P Chatel; D Luton; P Hammel
Journal:  J Perinatol       Date:  2013-12-19       Impact factor: 2.521

6.  Continued evidence for safety of endoscopic retrograde cholangiopancreatography during pregnancy.

Authors:  Sean Fine; Joshua Beirne; Silvia Delgi-Esposti; Fadlallah Habr
Journal:  World J Gastrointest Endosc       Date:  2014-08-16

7.  Acute bacterial cholangitis.

Authors:  Mamta K Jain; Rajeev Jain
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

8.  Sedation for endoscopic retrograde cholangiopancreatography (ERCP) in a pregnant patient.

Authors:  Leyla Iyilikci; Mesut Akarsu; Emine Kocaayan; Omer Topalak
Journal:  J Anesth       Date:  2007-01-30       Impact factor: 2.078

9.  Safety of endoscopic retrograde cholangiopancreatography in pregnancy: Fluoroscopy time and fetal exposure, does it matter?

Authors:  Ioana Smith; Monica Gaidhane; Allen Goode; Michel Kahaleh
Journal:  World J Gastrointest Endosc       Date:  2013-04-16

10.  Endoscopic retrograde cholangiopancreatography during pregnancy without radiation.

Authors:  Adem Akcakaya; Orhan Veli Ozkan; Ismail Okan; Orhan Kocaman; Mustafa Sahin
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.